Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin

समान संसाधन

• Dasatinib reverses the multidrug resistance of breast cancer MCF-7 cells to doxorubicin by downregulating P-gp expression via inhibiting the activation of ERK signaling pathway
  द्वारा: Chen, Ting, और अन्य
  प्रकाशित: (2014)
• Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7/ADR cells through autophagy induction: More than just down-regulation of MDR1
  द्वारा: Wang, Changyuan, और अन्य
  प्रकाशित: (2016)
• Cilastatin protects against imipenem-induced nephrotoxicity via inhibition of renal organic anion transporters (OATs)
  द्वारा: Huo, Xiaokui, और अन्य
  प्रकाशित: (2019)
• A New Chalcone Derivative C49 Reverses Doxorubicin Resistance in MCF-7/DOX Cells by Inhibiting P-Glycoprotein Expression
  द्वारा: Wang, Ting, और अन्य
  प्रकाशित: (2021)
• Organic anion transporters also mediate the drug–drug interaction between imipenem and cilastatin
  द्वारा: Zhu, Yanna, और अन्य
  प्रकाशित: (2020)